PRESCRIBERS |
|
|
Main prescribers: Pseudo-prescriptions |
69.85% |
|
INSURED CONSUMERS |
|
|
% of insured consumers |
50.94% |
|
Median age |
75 years |
|
Max/min ratio of the median age (by district) |
1.00 |
|
Percentage of women |
55.17% |
|
Ratio Preferential scheme/General scheme |
0.89 |
|
Coefficient of variation (2022) |
15.24 |
|
Max/min ratio of % of insured consumers (by district) |
1.67 |
|
CONSUMPTION |
|
|
Annual consumption (DDD) |
1,253,235 |
|
Consumption of DDD (per 100,000 insured persons) |
52,491.65 |
|
% DDD issued outside the insurance (approximate) |
5.23% |
|
Average annual consumption per insured consumer (DDD) |
1.03 |
|
% of insured consumers with > 3 times the average consumption |
0,00% |
|
Coefficient of variation 2015-2017 |
10.19 |
|
Coefficient of variation 2020-2022 |
13.71 |
Trend 2015-2022 |
-0.12% |
|
Trend 2015-2019 |
-1.39% |
|
Trend 2019-2022 |
1.61% |
DIRECT EXPENDITURE (DDD) |
|
|
Annual expenditure charged to the insurance |
16,298,691€ |
|
Average annual expenditure per insured person |
6.83 € |
|
Average patient share per insured consumer |
22.15% |
|
Max/min ratio of expenditure per insured person (by disctrict) |
1.66 |
|
% “Low-cost” medication |
NA |
|
Trend 2015-2022 |
7.65% |
|
Trend 2019-2022 |
31.10% |
|
On this table, when a statistical test has been performed, the data showing a significant difference is displayed on an yellow background, otherwise on a grey background.
CODES (ATC-5) |
LABELS |
J07BB |
INFLUENZA VACCINES |
The codes mentioned above can be used in rates and expenses, or only in expenses. We invite you to consult the full report for more information.
Click below to see the graph illustrating the evolution of the breakdown by volume of ATC codes used for the rates.
Older than or equal to 65 years
patients from elderly/nursing homes excluded
- ATC codes
- Age, sex and CV
- Rates by sex
- Reimbursement rate
- Trends by region
- Trends break
- Dot Plot
- Funnel plot
- DDD per patient by province
- Quantity per patient
- Distribution map
- Low-cost DDD
WE ARE INTERESTED IN YOUR OPINION
Do you have any experience in this area ? We listen to you !
Send us an email